SavedAdd your journal

Journals / Sakarya Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 4

Gadolinium Induced Acute Renal Failure: A Case Report

Gadolinyuma Bağlı Akut Böbrek Hasarı: Bir Olgu Sunumu

Ahmed Bilal Genç
Selçuk Yaylacı
Hamad Dheir
Serap Üngan
Necattin Fırat
Savaş Sipahi
Pages
706–709
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we wanted to report a 44-year-old female patient who developed AKI after abdominal MRI without any systemic disease and risk factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Contrast agents are one of the major causes of acute kidney injury.
📊
Key Findings & Data:Recently, it has been reported that gadolinium-based contrast agent (Gd-KM) used for magnetic resonance imaging (MRI) induces acute kidney injury (AKI).
💡
Conclusion & Impact:In this article, we wanted to report a 44-year-old female patient who developed AKI after abdominal MRI without any systemic disease and risk factors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Contrast agents are one of the major causes of acute kidney injury. Recently, it has been reported that gadolinium-based contrast agent (Gd-KM) used for magnetic resonance imaging (MRI) induces acute kidney injury (AKI). In this article, we wanted to report a 44-year-old female patient who developed AKI after abdominal MRI without any systemic disease and risk factors.

Özet

Kontrast maddeler akut böbrek hasarının önemli nedenlerinden biridir. Son zamanlarda, manyetik rezonans görüntüleme (MRG) incelemeleri için kullanılan gadolinyumbazlı kontrast maddenin (Gd-KM) akut böbrek hasarını (ABH) indüklediği bildirilmeye başlanmıştır. Bu yazıda sistemik hastalığı ve hiçbir risk faktörü olmayan 44 yaşbayan hasta, batın MRG sonrası ABH gelişimesi nedeniyle bildirilmesi amaçlandı.

🔖

Cite This Article

Genç, A. B., Yaylacı, S., Dheir, H., Üngan, S., Fırat, N., Sipahi, S. (2022). Gadolinium Induced Acute Renal Failure: A Case Report. Sakarya Tıp Dergisi, Cilt: 9 - Sayı: 4, 706–709. https://ajindex.com/articles/590433

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, et al. Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging. J Am Soc Nephrol 2006;17:2359–62. doi:10.1681/ ASN.2006060601
  2. Chien C-C, Wang H-Y, Wang J-J, Kan W-C, Chien T-W, Lin C-Y, et al. Risk of Acute Kidney Injury aft er Exposure to Gadolinium-Based Contrast in Patients with Renal Impairment. Ren Fail 2011;33:758–64. doi:10.3109/0886022X.2011.599911
  3. Takahashi EA, Kallmes DF, Mara KC, Harmsen WS, Misra S. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up. Diagn Interv Radiol 2018;24:378–84. doi:10.5152/dir.2018.18172
  4. Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019. doi:10.1016/j. carj.2019.04.001
  5. Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf 2008;3:67–75. http://www.ncbi.nlm.nih. gov/pubmed/18690983. Accessed 21 Jul 2019
  6. Fujisaki K, Ono-Fujisaki A, Kura-Nakamura N, Komune N, Hirakawa N, Tsuruya K, et al. Rapid deterioration of renal insuff iciency aft er magnetic resonance imaging with gadolinium-based contrast agent. Clin Nephrol 2011;75:251–4. doi:10.5414/cnp75251
  7. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron 2012;120:c179–84. doi:10.1159/000339789
  8. Tervahartiala P. Contrast media-induced renal tubular vacuolization aft er dehydration. A light and electron microscopic study in rats. Invest Radiol 1992;27:114–8. http://www.ncbi. nlm.nih.gov/pubmed/1601601. Accessed 21 Jul 2019
  9. Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006;98:14K-20K. doi:10.1016/j.amjcard.2006.01.020
  10. Akgun H, Gonlusen G, Cartwright J, Suki WN, Truong LD. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med 2006;130:1354–7. doi:10.1043/1543-2165(2006)130[1354:AGCMNA]2.0.CO;2
  11. Boyden TF, Gurm HS. Does gadolinium-based angiography protect against contrast-induced nephropathy?: a systematic review of the literature. Catheter Cardiovasc Interv 2008;71:687–93. doi:10.1002/ccd.21459
  12. Haustein J, L